DJIA 17,659.95 63.60 0.36%
NASDAQ 4,992.93 34.46 0.70%
S&P 500 2,066.29 8.65 0.42%
market minute promo

ImmunoGen (NASDAQ: IMGN)

14.32 0.52 (3.77%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $14.32 3.77%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.92
Previous Close $13.80
Daily Range $13.83 - $14.31
52-Week Range $5.34 - $15.88
Market Cap $1.2B
P/E Ratio -21.23
Dividend (Yield) $0.00 (0.0%)
Volume 647,730
Average Daily Volume 2,602,102
Current FY EPS -$0.70

Sector

Healthcare

Industry

Drug Makers

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

Why ImmunoGen Inc.'s Stock Soared Today

Shares of the struggling biopharma ImmunoGen skyrocketed today following a clinical update at the American Society of Clinical Oncology meeting. Here's what you need to know moving forward.

5 Healthy Stocks in the Top Biotech ETF - ETF News And Commentary

ImmunoGen's IMGN529 for B-Cell Malignancies Demonstrates Synergistic Activity with Rituximab in Prec

ImmunoGen's IMGN529 for B-Cell Malignancies Demonstrates Synergistic Activity with Rituximab in Preclinical Models of Non-Hodgkin Lymphoma

How 6 ASCO Biotech Winners Are Focusing on the Future of Cancer

ASCO Event Analyzer - 2015's Winners And Losers

Top-Performing Biotech and Drug Stocks During ASCO '15

Immunogen: Defeating Advanced Ovarian Cancer And Other Malignancies

ImmunoGen Surges on Positive Ovarian Cancer Study Data - Analyst Blog

ASCO - Surprise Boost For ImmunoGen In Ovarian Cancer

Strength Seen in ImmunoGen (IMGN): Stock Soars 71.9% - Tale of the Tape

Perilous Reversal Stock: Immunogen (IMGN)

See More IMGN News...

IMGN's Top Competitors

IMGN $14.32 (3.77%)
Current stock: IMGN
AMGN $153.45 (1.22%)
Current stock: AMGN
GILD $117.55 (1.81%)
Current stock: GILD
BIIB $403.30 (1.79%)
Current stock: BIIB